Cancer Information Highlights, March 29, 2017

Cancer Information Highlights, March 29, 2017

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more

New from NCI Food and Drug Administration (FDA) Approves New Use for Lenalidomide in Multiple Myeloma   With this new approval, patients with multiple myeloma can receive lenalidomide as maintenance therapy after receiving an autologous stem cell transplant for the disease to help keep the cancer from coming back. Colorectal Cancer Incidence Rising in Young Adults   Drs. Philip Rosenberg and William Anderson, of NCI’s Biostatistics Branch, discuss a recent study that reported an increase in colorectal cancer cases among adults younger than 50 in the United States. Video—Ovarian Cancer: Did You Know?   Learn about the different types of ovarian cancer, survival and other statistics, which groups are most at risk, and common risk factors. PDQ Summary Updates Unusual Cancers of Childhood We’ve revised our PDQ summary on unusual childhood cancers. Thymoma and thymic carcinoma are now discussed as separate tumor types and information specific to thymic carcinoma has been added. Drug Information Updates New Drug Approved for Breast Cancer We’ve added a new drug summary for ribociclib. It was recently approved by the FDA to be used with other drugs to treat certain types of breast cancer. It is used in postmenopausal women who have not been treated with hormone therapy. Pembrolizumab for Hodgkin Lymphoma Our pembrolizumab summary has been updated to include a recent approval from the FDA. Pembrolizumab is now approved to treat Hodgkin lymphoma in patients whose cancer has not responded to treatment or has relapsed after treatment.

Also of Interest Cancer Screening Cancer screening can help doctors find and treat several types of cancer early. Learn about the tests that can help find certain cancers before symptoms appear and what risks may be associated with screening. NCI-Designated Cancer Centers There are currently 69 NCI-Designated Cancer Centers located in 35 states and Washington, DC. Learn about the Cancer Centers Program, why it is important to cancer research, and how to find a cancer center. Head and Neck Cancer Learn about the different types of cancers that start in the head and neck area, treatment for the different types, risk factors, and ongoing research.